Responses
Therapeutics
Randomised controlled trial
Hydroxycarbamide for very young children with sickle cell anaemia: no effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity
Compose a Response to This Article
Other responses
No responses have been published for this article.